Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Salud pública Méx ; 61(4): 542-544, Jul.-Aug. 2019.
Article in English | LILACS | ID: biblio-1099331

ABSTRACT

Abstract: Prostate-specific antigen (PSA)-based early detection for prostate cancer is the subject of intense debate. Implementation of organized prostate cancer screening has been challenging, in part because the PSA test is so amenable to opportunistic screening. To the extent that access to cancer screening tests increases in low- and middle-income countries (LMICs), there is an urgent need to thoughtfully evaluate existing and future cancer screening strategies to ensure benefit and control costs. We used Mexico's prostate cancer screening efforts to illustrate the challenges LMICs face. We provide five considerations for policymakers for a smarter approach and implementation of PSA-based screening.


Resumen : El uso del Antígeno Prostático Específico (APE) para tamizaje para cáncer de próstata sigue siendo tema de amplio debate. La implementación de estrategias de tamiz organizado de cáncer de próstata ha sido un reto en parte porque la prueba de APE se presta para detección oportunista. A medida que aumenta el acceso a las pruebas de detección de cáncer en los países de ingresos bajos y medianos (PIBM), existe la necesidad urgente de evaluar cuidadosamente las estrategias actuales y futuras de detección oportuna de cáncer para garantizar su beneficio y controlar sus costos. Utilizamos los esfuerzos de tamizaje de cáncer de próstata de México para ilustrar los retos para PIBM. Ofrecemos cinco consideracio nes dirigidas a tomadores de decisión que permitan contar con estrategias racionales de implementación de tamizaje para cáncer de próstata basado en el uso de APE.


Subject(s)
Humans , Male , Middle Aged , Aged , Prostatic Neoplasms/diagnosis , Prostate-Specific Antigen/blood , Developing Countries , Early Detection of Cancer/methods , Policy Making , Prostatic Neoplasms/blood , Health Education , Age Factors , Outcome Assessment, Health Care , Cost-Benefit Analysis , Mexico
2.
Int. braz. j. urol ; 44(5): 874-881, Sept.-Oct. 2018. tab
Article in English | LILACS | ID: biblio-975640

ABSTRACT

ABSTRACT Purpose: To provide data of the incidence and management of common urological malignancies in renal transplant recipients. Materials and Methods: We conducted a retrospective analysis of a prospective database from August 1967 to August 2015. A descriptive analysis of the sample was performed. Results: Among 1256 consecutive RTR a total of 88 patients developed malignancies (7%). There were 18 genitourinary tumors in the 16 patients (20.45 % of all malignant neoplasms), incidence of 1.27%. The most common neoplasm encounter was renal cancer (38.8%), followed by urothelial carcinoma (33.3%). Median follow-up of transplantation was 197 months (R, 36-336). Mean time from RT to cancer diagnosis 89±70 months (R, 12-276). CsA and AZA was the most common immunosuppression regimen in 68.75%. Mean follow-up after diagnosis was 103±72 months (R 10-215). Recurrence free survival rate of 100%. Overall survival of 89.5% of the sample; there were two non-related cancer deaths during follow-up. Conclusions: The incidence of neoplasms in RTR was lower than in other series, with favorable functional and oncologic results after treatment. This suggests that actions to reduce the risk of these malignancies as well as a strict follow-up are mandatory for an early detection and treatment.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Aged , Young Adult , Kidney Transplantation/adverse effects , Urogenital Neoplasms/therapy , Urogenital Neoplasms/epidemiology , Incidence , Prospective Studies , Retrospective Studies , Kidney Transplantation/statistics & numerical data , Mexico/epidemiology , Middle Aged
3.
Rev. méd. IMSS ; 33(5): 505-7, sept.-oct. 1995. ilus
Article in Spanish | LILACS | ID: lil-174189

ABSTRACT

La medición de la presión arterial por método directo es una actividad cotidiana en las unidades de cuidados intensivos. Se hace énfasis en un método antiguo y a la vez sencillo, que permite la medición confiable y precisa de la presión arterial media sistémica, en situaciones de apremio, en lugares donde no se cuente con los recursos tecnológicos, durante el traslado de pacientes, cuando el equipo especial falla o existe duda acerca del valor indicado por los dispositivos electrónicos para vigilancia constante de signos vitales. En tales condiciones puede utilizarse una línea de agua, similar en su mecánica y uso a una línea para medir presión venosa central convencional, pero de mayor longitud. El principio fisico es infalible, la línea se prepara fácil y rápidamente, el método está libre de riesgo y a través de varios años lo hemos empleado como una buena alternativa de los métodos usuales de medición directa


Subject(s)
Emergency Medicine , Hypotension/prevention & control , Blood Pressure/physiology , Culturally Appropriate Technology
SELECTION OF CITATIONS
SEARCH DETAIL